{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:11:44Z","timestamp":1720689104439},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Intraven\u00f6se Medikamenteninteraktionen finden im Bereich der Intensivmedizin immer gr\u00f6\u00dfere Beachtung, da dort eine Vielzahl von Medikamenten \u00fcber eine begrenzte Anzahl an i.v.-Zug\u00e4ngen appliziert werden muss; doch treten sie auch im Routinebetrieb im OP auf. Der folgende Fallbericht soll die Aufmerksamkeit auf die Medikamentenkombination Theodrenalin\/Cafedrin mit verschiedenen Antibiotika lenken.<\/jats:p>","DOI":"10.1007\/s00101-022-01217-5","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T09:05:48Z","timestamp":1669021548000},"page":"109-112","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medikamenteninteraktion zwischen Ceftriaxon und Theodrenalin\/Cafedrin"],"prefix":"10.1007","volume":"72","author":[{"given":"Christina","family":"Werzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Hofmann-Kiefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"1217_CR1","unstructured":"Fachinformation Akrinor\u00ae 200\u202fmg\/2\u202fml + 10\u202fmg\/2\u202fml Injektionsl\u00f6sung. https:\/\/www.ratiopharm.de\/produkte\/details\/praeparate\/praeparatedaten\/detail\/pzn-10130318.html. Zugegriffen: 30. Dez. 2021"},{"key":"1217_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fphar.2017.00068","volume":"8","author":"B Bein","year":"2017","unstructured":"Bein\u00a0B, Christ\u00a0T, Eberhart\u00a0LHJ (2017) Cafedrine\/Theodrenaline (20:1) is an established alternative for the management of arterial hypotension in Germany\u2014A review based on a\u00a0systematic literature search. Front Pharmacol 8:68. https:\/\/doi.org\/10.3389\/fphar.2017.00068","journal-title":"Front Pharmacol"},{"key":"1217_CR3","first-page":"356","volume":"47","author":"HKT Knoth","year":"2006","unstructured":"Knoth\u00a0HKT (2006) Akrinor\u00ae-Injektionsl\u00f6sung: Ein klinisch relevantes Pr\u00e4parat bleibt verkehrsf\u00e4hig! Anasth Intensivmed 47:356\u2013361","journal-title":"Anasth Intensivmed"},{"key":"1217_CR4","first-page":"70","volume":"19","author":"HHU Wacha","year":"2010","unstructured":"Wacha\u00a0HHU, Isenmann\u00a0R, Kujath\u00a0P, Lebert\u00a0C, Naber\u00a0K, Salzberger\u00a0B (2010) Perioperative Antibiotika-Prophylaxe. Chemother\u00a0J 19:70\u201384","journal-title":"Chemother J"},{"key":"1217_CR5","unstructured":"Ceftriaxon \u2013 Chemie. https:\/\/www.vetpharm.uzh.ch\/wir\/00007338\/4595_01.html. Zugegriffen: 23. Jan. 2022"},{"key":"1217_CR6","first-page":"164","volume-title":"Veterinary drug handbook","author":"DC Plumb","year":"2002","unstructured":"Plumb\u00a0DC (2002) Veterinary drug handbook, 6.\u00a0Aufl. Wiley-Blackwell, Hoboken, S 164\u2013166","edition":"6"},{"key":"1217_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbrc.2011.02.053","volume":"406","author":"S Chutipongtanate","year":"2011","unstructured":"Chutipongtanate\u00a0S, Thongboonkerd\u00a0V (2011) Ceftriaxone crystallization and its potential role in kidney stone formation. Biochem Biophys Res Commun 406:396\u2013402. https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.053","journal-title":"Biochem Biophys Res Commun"},{"key":"1217_CR8","unstructured":"Fachinformation Ceftriaxon Eberth 2g. https:\/\/www.eberth-arzneimittel.com\/fileadmin\/user_upload\/produkte\/ceftriaxon_mit_loesungsmittel\/fi\/FI_Ceftriaxon_Eberth_Loesungsmittel_Premium_2g.pdf. Zugegriffen: 23. Jan. 2022"},{"key":"1217_CR9","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1542\/peds.2008-3080","volume":"123","author":"JS Bradley","year":"2009","unstructured":"Bradley\u00a0JS, Wassel\u00a0RT, Lee\u00a0L, Nambiar\u00a0S (2009) Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics 123:e609\u2013e613. https:\/\/doi.org\/10.1542\/peds.2008-3080","journal-title":"Pediatrics"},{"key":"1217_CR10","unstructured":"Beurteilung derzeitiger Infusionsl\u00f6sungen. https:\/\/www.physioklin.de\/physiofundin\/beurteilung-derzeitiger-infusionsloesungen.html. Zugegriffen: 23. Jan. 2022"},{"key":"1217_CR11","unstructured":"L\u00f6slichkeitsprodukt. http:\/\/www.chemgapedia.de\/vsengine\/vlu\/vsc\/de\/ch\/11\/aac\/vorlesung\/kap_8\/vlus\/thermodynamik_loeslichkeitsprodukt.vlu\/Page\/vsc\/de\/ch\/11\/aac\/vorlesung\/kap_8\/kap8_6\/kap8_6d.vscml.html. Zugegriffen: 13. Jan. 2022"},{"key":"1217_CR12","unstructured":"Was tun, wenn der Wirkstoff ausf\u00e4llt? https:\/\/www.deutsche-apotheker-zeitung.de\/daz-az\/2018\/daz-24-2018\/was-tun-wenn-der-wirkstoff-ausfaellt. Zugegriffen: 13. Jan. 2022"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-022-01217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-022-01217-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-022-01217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:42:58Z","timestamp":1675251778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-022-01217-5"}},"subtitle":["Ein Fallbeispiel"],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1007\/s00101-022-01217-5","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Werzer, S.\u00a0Sch\u00e4fer und K.\u00a0Hofmann-Kiefer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}